ABM LLC

ABM LLC, a Tbilisi, Georgia–based for-profit limited liability company, supplies advanced scientific and laboratory instrumentation to U.S. Department of Defense research agencies and the Department of State as a prime contractor exclusively (100% of awards), competing on full-and-open solicitations without set-aside designation.

ABM LLC specializes in procurement and maintenance of sophisticated laboratory equipment for defense and medical research infrastructure. The vendor's product portfolio centers on specialized instrumentation including KingFisher Flex systems, ultra-low temperature freezers, PCR systems, flow cytometers, capillary sequencers, bio analyzers, and related lifecycle maintenance services. Representative prime work includes a $67,914 firm fixed-price purchase order from the Defense Health Agency (effective March 1, 2026, through February 28, 2027) for maintenance service renewal of Walter Reed Army Institute of Research (WRAIR) advanced biological instrumentation; an $81,032.67 purchase order from the Defense Health Agency (awarded April 30, 2025) for three KingFisher Flex laboratory instruments delivered to WRAIR through a State Department RFQ for the U.S. Embassy in Tbilisi; and a $56,779.78 purchase order from the Defense Advanced Research Projects Agency (awarded April 30, 2024) for a WRAIR lifecycle replacement floor centrifuge.

Customer concentration clusters around defense research entities. The Defense Advanced Research Projects Agency, the Department of State's U.S. Embassy Tbilisi, the Department of the Navy Bureau of Medicine and Surgery, the Defense Health Agency, and the Department of the Army together account for 92% of awards by count and 93% of combined potential value. DARPA leads both rankings with three awards totaling $217 thousand in combined potential value; the State Department and Navy tie at two awards each ($166 thousand and $159 thousand respectively). The vendor operates across six distinct federal customer agencies with a total portfolio of twelve prime awards spanning nine years (first award September 2017; most recent March 2026) valued at $899 thousand combined potential value, of which $853 thousand has been obligated. Activity has been episodic — one award per year in 2021 and 2022, two awards in 2024, and one each in 2025 and 2026 — with only one award (potential value $68 thousand) scheduled for completion within the next twenty-four months.